Duloxetine Purification via pH Adjustment and Low-Temperature Precipitation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional methods for purifying duloxetine hydrochloride, such as crystallization using high temperatures, are inefficient in terms of yield and energy consumption, and can cause decomposition due to heat stress, especially for substances with a small difference in solubility at high and low temperatures.
Innovation Solution
A method involving the release of duloxetine base from its hydrochloride using an organic or inorganic base in an aqueous environment, followed by extraction into a suitable organic solvent and subsequent transformation back into hydrochloride using hydrochloric acid, or dissolving in methanol and precipitating with a less polar solvent at low temperatures to achieve high purity with reduced energy and material demands.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If crystallization is performed using high temperature heating, then purity of duloxetine hydrochloride is improved, but energy consumption increases and decomposition occurs
Solution Approach 1:
The invention changes the temperature parameter from high temperature heating to low temperature operation. The process uses a two-stage pH adjustment method at low temperatures (0-25°C) to achieve purification without thermal decomposition, thereby maintaining purity while dramatically reducing energy consumption compared to conventional high-temperature crystallization methods
Solution Approach 2:
The invention replaces the thermal field (heating-based crystallization) with a chemical field (pH-controlled precipitation). By using controlled pH adjustment with bases like sodium carbonate or potassium carbonate followed by acidification, the process achieves purification through chemical equilibria rather than thermal driving forces, eliminating the need for high energy input
2Manufacturing precision
If crystallization is performed using high temperature heating, then purity of duloxetine hydrochloride is improved, but decomposition occurs due to heat stress
Solution Approach 1:
The invention changes the temperature parameter from high temperature heating to low temperature operation. The process uses a two-stage pH adjustment method at low temperatures (0-25°C) to achieve purification without thermal decomposition, thereby maintaining purity while dramatically reducing energy consumption compared to conventional high-temperature crystallization methods
Solution Approach 2:
The invention replaces the thermal field (heating-based crystallization) with a chemical field (pH-controlled precipitation). By using controlled pH adjustment with bases like sodium carbonate or potassium carbonate followed by acidification, the process achieves purification through chemical equilibria rather than thermal driving forces, eliminating the need for high energy input
3Manufacturing precision
If conventional crystallization method is used, then purity is improved, but yield decreases due to small solubility difference at high and low temperatures
Solution Approach 1:
The invention introduces pH control as an intermediary parameter to mediate the purification process. By adjusting pH to convert duloxetine hydrochloride to its free base form and then re-protonating it, the process achieves separation and purification without relying on solubility differences, thereby maintaining high yield while achieving high purity
Solution Approach 2:
The invention changes the controlling parameter from temperature-dependent solubility to pH-dependent protonation state. This parameter change allows the process to overcome the limitation of small solubility differences, enabling high purification efficiency without the yield loss that would result from extensive recrystallization cycles
4Manufacturing precision
If conventional crystallization method is used, then purity is improved, but production time and energy requirements increase
Solution Approach 1:
The invention performs preliminary pH adjustment to convert the hydrochloride salt to the free base form before the main purification step. This preliminary action simplifies the subsequent filtration and washing steps, reducing overall production time while maintaining high purity levels
Solution Approach 2:
The invention replaces the thermal field (heating-based crystallization) with a chemical field (pH-controlled precipitation). By using controlled pH adjustment with bases like sodium carbonate or potassium carbonate followed by acidification, the process achieves purification through chemical equilibria rather than thermal driving forces, eliminating the need for high energy input
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enhances the yield and purity of duloxetine hydrochloride while minimizing decomposition and energy requirements, offering an efficient and cost-effective purification process suitable for large-scale production.
Implementation Method 1
releasing the duloxetine base from its crystalline hydrochloride by the action of an organic or inorganic base in an aqueous environment
Implementation Method 2
extracted into a suitable organic solvent
Implementation Method 3
transforming the duloxetine base to the hydrochloride by action of hydrochloric acid or gaseous hydrochloride in an organic solvent
Implementation Method 4
dissolving in methanol and precipitating with a less polar solvent at low temperatures
Data Source
AI summary
A method of purification of (5)-7V-methyl-3-(l-naphtyloxy)-3-(2-thienyl) propylamine hydrochloride of formula I, comprising (a) transformation of the substance of formula I to its free base by the action of an organic or inorganic base in an aqueous environment; and (b) transformation of the base of the substance of formula I to crystalline hydrochloride by the action of hydrochloric acid or gaseous HCl in an organic solvent or a mixture of organic solvents. A method of purification of (S)-N-methyl-3-(l-naphtyloxy)-3-(2-thienyl) propylamine hydrochloride of formula I, comprising dissolution of this substance in a minimum quantity of methanol containing 0 to 50% of water and its transformation back to the solid phase (precipitation) by addition of a less polar solvent.